Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes

Health

Ozempic Linked To Lower Alzheimer's Risk In People With Type 2 Diabetes

By NBC News

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with Type 2 diabetes, according to a study published Thursday in the journal Alzheimer’s & Dementia. The study adds to evidence tha ...Read more